Technological Innovations in Thyroid Cancer Surgery

Abstract

Thyroid cancer is the fifth most common cancer in the USA, with differentiated subtype accounting for more than 95% of neoplasm. Surgery remains the mainstay of treatment, either with lobectomy or total thyroidectomy. In the last decades, many technological innovations have been introduced in this field. The aim of this review is to illustrate the most recent advances regarding the classical surgical approach, particularly regarding hemostatic devices, parathyroid identification with fluorescence systems, intraoperative identification of lymph node metastases, and intraoperative neuromonitoring.

Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience

“…Thyroid cancer is the fifth most common cancer in the USA, and over 44 000 new cases occurred in men and women in 2021. The incidence of thyroid cancer is still rising worldwide, mostly due to the increased use of diagnostic imaging and surveillance, and the diffusion of more accurate cytological classifications (6)(7)(8)(9)(10)(11)(12). Differentiated thyroid cancer (DTC) is the most common subtype, accounting for more than 95% of cases, and it is generally considered a tumor with a good prognosis, although a certain number of patients experience a poor clinical outcome (6,8,(13)(14)(15).…”

Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer

“…Thyroid cancer (THCA) as the most frequently diagnosed malignancy had high incidence in females worldwide [ 1 ]. According to the annual cancer study report, there had been 62,450 estimated new cases and 1,950 estimated deaths in 2015 [ 2 ], however, the estimated new cases have dropped to 43,720, and the deaths are 2,120 in 2023 [ 3 ], indicating the incidence of THCA has greatly decreased and the mortality is stable [ 4 ] causing tremendous threat to people’s life and health.…”

Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification

“…However, patients with vascular invasion, extra-thyroidal invasion, or distant metastasis often face a poor prognosis [ 2 , 3 ]. Standard treatment (surgery or radioactive iodine therapy) is effective for most patients [ 4 ], but there are still some patients who are not sensitive to available treatments [ 5 ]. Therefore, a deeper knowledge on THCA pathogenesis is essential to explore new therapeutic measures and to improve its prognosis.…”